156 related articles for article (PubMed ID: 30237575)
1. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings.
Roche MI; Griesemer I; Khan CM; Moore E; Lin FC; O'Daniel JM; Foreman AKM; Lee K; Powell BC; Berg JS; Evans JP; Henderson GE; Rini C
Genet Med; 2019 May; 21(5):1092-1099. PubMed ID: 30237575
[TBL] [Abstract][Full Text] [Related]
2. The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study.
Rini C; Khan CM; Moore E; Roche MI; Evans JP; Berg JS; Powell BC; Corbie-Smith G; Foreman AKM; Griesemer I; Lee K; O'Daniel JM; Henderson GE
Genet Med; 2018 Jul; 20(7):760-769. PubMed ID: 29261173
[TBL] [Abstract][Full Text] [Related]
3. Future-oriented Emotions and Decisions to Receive Genomic Testing Results Among U.S. Adults of African Ancestry.
Gillman AS; Iles IA; Klein WMP; Biesecker BB; Lewis KL; Biesecker LG; Ferrer RA
Ann Behav Med; 2023 Apr; 57(5):418-423. PubMed ID: 36356050
[TBL] [Abstract][Full Text] [Related]
4. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
[TBL] [Abstract][Full Text] [Related]
5. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
Bijlsma RM; Wessels H; Wouters RHP; May AM; Ausems MGEM; Voest EE; Bredenoord AL
Fam Cancer; 2018 Apr; 17(2):309-316. PubMed ID: 28852913
[TBL] [Abstract][Full Text] [Related]
6. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
[TBL] [Abstract][Full Text] [Related]
7. Associations of perceived norms with intentions to learn genomic sequencing results: Roles for attitudes and ambivalence.
Reid AE; Taber JM; Ferrer RA; Biesecker BB; Lewis KL; Biesecker LG; Klein WMP
Health Psychol; 2018 Jun; 37(6):553-561. PubMed ID: 29745680
[TBL] [Abstract][Full Text] [Related]
8. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
9. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.
Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL
AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844
[TBL] [Abstract][Full Text] [Related]
10. Toward greater understanding of patient decision-making around genome sequencing.
Hull LE; Vassy JL
Per Med; 2018 Jan; 15(1):57-66. PubMed ID: 29714114
[TBL] [Abstract][Full Text] [Related]
11. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.
Facio FM; Eidem H; Fisher T; Brooks S; Linn A; Kaphingst KA; Biesecker LG; Biesecker BB
Eur J Hum Genet; 2013 Mar; 21(3):261-5. PubMed ID: 22892536
[TBL] [Abstract][Full Text] [Related]
12. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.
Lemke AA; Bick D; Dimmock D; Simpson P; Veith R
Clin Genet; 2013 Sep; 84(3):230-6. PubMed ID: 23163796
[TBL] [Abstract][Full Text] [Related]
14. Genomic knowledge in the context of diagnostic exome sequencing: changes over time, persistent subgroup differences, and associations with psychological sequencing outcomes.
Rini C; Henderson GE; Evans JP; Berg JS; Foreman AKM; Griesemer I; Waltz M; O'Daniel JM; Roche MI
Genet Med; 2020 Jan; 22(1):60-68. PubMed ID: 31312045
[TBL] [Abstract][Full Text] [Related]
15. Research Participants' Preferences for Hypothetical Secondary Results from Genomic Research.
Wynn J; Martinez J; Duong J; Chiuzan C; Phelan JC; Fyer A; Klitzman RL; Appelbaum PS; Chung WK
J Genet Couns; 2017 Aug; 26(4):841-851. PubMed ID: 28035592
[TBL] [Abstract][Full Text] [Related]
16. The role of future-oriented affect in engagement with genomic testing results.
Gillman AS; Iles IA; Klein WMP; Biesecker BB; Lewis KL; Biesecker LG; Ferrer RA
J Behav Med; 2022 Feb; 45(1):103-114. PubMed ID: 34480685
[TBL] [Abstract][Full Text] [Related]
17. Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.
Brothers KB; East KM; Kelley WV; Wright MF; Westbrook MJ; Rich CA; Bowling KM; Lose EJ; Bebin EM; Simmons S; Myers JA; Barsh G; Myers RM; Cooper GM; Pulley JM; Rothstein MA; Clayton EW
Genet Med; 2017 Mar; 19(3):337-344. PubMed ID: 27561086
[TBL] [Abstract][Full Text] [Related]
18. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
[TBL] [Abstract][Full Text] [Related]
19. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives.
Houdayer F; Putois O; Babonneau ML; Chaumet H; Joly L; Juif C; Michon CC; Staraci S; Cretin E; Delanoue S; Charron P; Chassagne A; Edery P; Gautier E; Lapointe AS; Thauvin-Robinet C; Sanlaville D; Gargiulo M; Faivre L
Eur J Med Genet; 2019 Oct; 62(10):103711. PubMed ID: 31265899
[TBL] [Abstract][Full Text] [Related]
20. Defining categories of actionability for secondary findings in next-generation sequencing.
Moret C; Mauron A; Fokstuen S; Makrythanasis P; Hurst SA
J Med Ethics; 2017 May; 43(5):346-349. PubMed ID: 28039284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
